(BIIB) Biogen - Performance -36.8% in 12m
Compare BIIB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-71.80%
#118 in Group
Rel. Strength
17.70%
#6288 in Universe
Total Return 12m
-36.76%
#77 in Group
Total Return 5y
-57.83%
#71 in Group
P/E 12.4
45th Percentile in Group
P/E Forward 8.92
38th Percentile in Group
PEG 6.24
95th Percentile in Group
FCF Yield 10.8%
94th Percentile in Group
12m Total Return: BIIB (-36.8%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: BIIB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIIB
Total Return (including Dividends) | BIIB | XBI | S&P 500 |
---|---|---|---|
1 Month | -7.33% | -5.85% | -3.01% |
3 Months | -12.45% | -11.95% | -3.15% |
12 Months | -36.76% | -11.00% | 10.19% |
5 Years | -57.83% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | BIIB | XBI | S&P 500 |
1 Month | -77.8% | -59.8% | -5.5% |
3 Months | -53.8% | -70.5% | -58.4% |
12 Months | -90.4% | -6.9% | 84.1% |
5 Years | -59.5% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #84 | -1.58% | -4.46% |
3 Month | #59 | -0.57% | -9.61% |
12 Month | #75 | -28.9% | -42.6% |
5 Years | #75 | -58.1% | -81.6% |
FAQs
Does BIIB Biogen outperforms the market?
No,
over the last 12 months BIIB made -36.76%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months BIIB made -12.45%, while XBI made -11.95%.
Over the last 3 months BIIB made -12.45%, while XBI made -11.95%.
Performance Comparison BIIB vs Indeces and Sectors
BIIB vs. Indices BIIB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.08% | -4.32% | -30.3% | -47.0% |
US NASDAQ 100 | QQQ | -6.10% | -3.27% | -29.5% | -45.4% |
US Dow Jones Industrial 30 | DIA | -7.28% | -5.19% | -31.2% | -46.3% |
German DAX 40 | DAX | -5.78% | -3.95% | -47.1% | -58.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -6.79% | -7.56% | -15.1% | -45.9% |
Hongkong Hang Seng | HSI | -9.05% | -10.1% | -21.1% | -54.1% |
India NIFTY 50 | INDA | -8.11% | -15.2% | -19.9% | -37.5% |
Brasil Bovespa | EWZ | -7.19% | -15.6% | -22.3% | -25.0% |
BIIB vs. Sectors BIIB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.54% | -3.52% | -38.4% | -56.0% |
Consumer Discretionary | XLY | -7.84% | -3.50% | -33.7% | -50.8% |
Consumer Staples | XLP | -9.87% | -5.49% | -31.1% | -47.8% |
Energy | XLE | -8.17% | -15.4% | -35.9% | -37.6% |
Financial | XLF | -7.56% | -4.63% | -42.5% | -59.0% |
Health Care | XLV | -7.50% | -4.17% | -25.6% | -38.5% |
Industrial | XLI | -7.39% | -6.64% | -29.6% | -45.3% |
Materials | XLB | -8.18% | -7.84% | -22.2% | -32.8% |
Real Estate | XLRE | -9.12% | -4.64% | -27.2% | -50.1% |
Technology | XLK | -5.95% | -3.32% | -25.2% | -38.8% |
Utilities | XLU | -10.4% | -8.15% | -29.4% | -62.0% |
Aerospace & Defense | XAR | -6.48% | -8.61% | -34.2% | -57.7% |
Biotech | XBI | -2.52% | -1.48% | -12.6% | -25.8% |
Homebuilder | XHB | -7.58% | -7.48% | -10.9% | -29.1% |
Retail | XRT | -9.38% | -6.83% | -26.2% | -32.0% |